DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Schrieber SJ, Pfuma-Fletcher E, Wang X. et al.
Considerations for biologic product drug-drug interactions: a regulatory
perspective.
Clin Pharmacol Ther 2019;
105: 1332-1334
We do not assume any responsibility for the contents of the web pages of other providers.